Trial intelligence / Profile preview

Triamcinolone With or Without Antifungal Therapy for Multiple Keloids

ChiCTR2100054314Phase 4Recruiting

Sponsor
Southern Medical University Dermatology Hospital
Start
Jun 2021
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 4 trial of triamcinolone acetonide, ketoconazole, itraconazole and Salvax in keloid (4 arms), sponsored by Southern Medical University Dermatology Hospital. Primary endpoints: Color of keloid lesions, Thickness of keloid lesions and 2 more. Started Jun 2021; status: recruiting.

02

Drugs

triamcinolone acetonideketoconazoleitraconazoleSalvax
03

Conditions

keloid

Beyond the preview

Go deeper on ChiCTR2100054314.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100054314.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call